« Return to News | Study Conduct

BRANY to collaborate with U of Miami

Wednesday, May 23, 2012 01:50 PM

BRANY (Biomedical Research Alliance of New York) has agreed to provide education content for the Collaborative Institutional Training Initiative (CITI) at the University of Miami for use on their online clinical research training program.

“Continuing education is a key component of maintaining competency among clinical research professionals,” said Kimberly Irvine, executive vice president of operations at BRANY. “We are pleased to collaborate with CITI and have our course content accessible to the organizations, hospitals and learners that rely on CITI for research education.”

CITI’s comprehensive online program will now include exclusive peer reviewed content developed by BRANY on clinical study design and statistical methods, which will be part of a new CITI online program in comprehensive research study design.

“CITI is committed to providing the best in clinical research ethics education,” said Paul Braunschweiger, Ph.D., CITI founder and program director. “This collaboration allows us to offer increasingly robust educational courses to our learners from around the world.”

The new research study design course is expected to launch in early 2013.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.